SCHEMBL8345671

SCHEMBL8345671

CSCNCC1=CCN(C)CC1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
QDPR P09417 2/20 0.33
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9130250 0.77 QDPR (0.38) QDPRSIGMAR1
SCHEMBL9127424 0.74 QDPR (0.36) QDPRSIGMAR1
SCHEMBL7607024 0.70
SCHEMBL13990234 0.70 QDPR (0.37) QDPR
SCHEMBL4700734 0.69
SCHEMBL6953079 0.69
SCHEMBL15370330 0.69
SCHEMBL14311964 0.69
SCHEMBL8730552 0.68 QDPR (0.37) QDPR
SCHEMBL13599361 0.68 QDPR (0.37) QDPRSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003092580-A2 METHODS AND COMPOSITIONS FOR TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS AND NOVEL COMPOUNDS USEFUL THEREFOR ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) 2003-11-13 WO disclosed